Aug 7, 2024 06:00AM
May 8, 2024 06:00AM
Feb 27, 2024 06:00AM
Feb 26, 2024 06:00AM
Nov 9, 2023 04:01PM
Sep 19, 2023 06:15AM
Aug 2, 2023 06:00AM BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results
Jul 12, 2023 07:00AM
Nov 9, 2022 07:00AM
Aug 4, 2022 07:00AM
Jul 14, 2022 06:00AM
Jun 13, 2022 07:00AM
May 5, 2022 07:00AM
Apr 11, 2022 06:00AM IRC Determines BRUKINSA® (Zanubrutinib) Demonstrates Superior Overall Response Rate Versus Ibrutinib in Final Response Analysis of ALPINE Trial in Chronic Lymphocytic Leukemia
Mar 11, 2022 07:00AM
Feb 25, 2022 07:00AM
Feb 22, 2022 07:00AM
Jan 24, 2022 05:00AM
Jan 6, 2022 06:38AM
Jan 6, 2022 03:30AM
Dec 20, 2021 06:15AM BeiGene Expands Collaboration with Novartis to Develop and Commercialize BeiGene’s TIGIT Inhibitor and Market Five Novartis Oncology Medicines in China Broad Markets

15,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All